{
    "nct_id": "NCT04081753",
    "official_title": "Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy",
    "inclusion_criteria": "Patients who have acute myeloid leukemia (AML) and are candidates for consolidation chemotherapy with high dose cytarabine (HiDAC) after successful remission induction chemotherapy\n\n* Both male and female\n* Age 18 years and older\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "Patients who have already developed febrile neutropenia during their hospitalization for their consolidative cycle of chemotherapy will not be eligible for monitoring for that cycle; however, these patients will be able to participate in subsequent cycle if they do not develop febrile neutropenia during their subsequent HiDAC hospitalization.\n\nâ€¢ If a patient is admitted to the hospital between cycles of chemotherapy for reasons other than febrile neutropenia or its sequelae, they will be taken off study for that cycle and data not collected while they are admitted",
    "miscellaneous_criteria": ""
}